Product Description

A noted psychiatrist examines the current status of Prozac in America, including the latest research, as well as personal observations into how and why this drug has become so popular in the quest to cure personality problems. Reprint. Tour."

Product Details

• Amazon Sales Rank: #101767 in Books
• Published on: 1997-09-01
• Original language: English
• Number of items: 1
• Binding: Paperback
• 448 pages

Features

• ISBN13: 9780140266719
• Condition: NEW
• Notes: Brand New from Publisher. No Remainder Mark.
• Click here to view our Condition Guide and Shipping Prices

Amazon.com Review
Psychiatrist Peter Kramer's book Listening to Prozac created a sensation when it was released in 1993, and it remains the most fascinating look at the new generation of antidepressants. Kramer found that the changes in brain chemistry brought about by Prozac had a wide variety of effects, often giving users greater feelings of self-worth and confidence, less sensitivity to social rejection, and even a greater willingness to take risks. He cites cases of mildly depressed patients who took the drug and not only felt better but underwent remarkable personality transformations--which he (along with many of the book's readers) found disconcerting, leading him to question whether the medicated or unmedicated version was the person's "real" self. Kramer has been criticized for seeming to advocate Prozac over psychotherapy or as a way of achieving personality changes not directly related to the disease of depression, such as improving one's social confidence or job performance. In fact, he makes no such recommendations; he was simply the first popular writer to suggest that these changes might occur. (He answers those critics in the afterword to this 1997 edition.) For anyone considering taking antidepressants or wanting a better understanding of the effects these drugs are having on our society, Listening to Prozac is a very important book.

From Library Journal
Kramer, a practicing psychiatrist, finds that the antidepressant Prozac is a powerful drug that lifts the veil of depression from most patients without significant side effects. While he unquestionably supports the use of medication to alleviate illness, he questions using drugs to make a person feel "better than well." It is the remarkable ability of Prozac to create personality changes that he finds disturbing. Is it ethical to prescribe a drug that increases a person's self-confidence, resilience, and energy level without any ill effect, when there is no underlying manifestation of illness? What is the essence of personhood and what are the philosophical implications of using drugs to alter personality? Both Kramer's unequivocal endorsement of Prozac for the treatment of depression and the questions he raises about the use of drugs for mood alteration are controversial. A glossary would have been a useful addition for lay readers. Recommended.
- Carol R. Glatt, VA Medical Ctr. Lib., Philadelphia
Copyright 1993 Reed Business Information, Inc.

From Kirkus Reviews
A provocative volume that sets up the mood-altering Prozac as a tool to examine the growing--and often troubling--use of drugs in the treatment of psychological illness. Brown University professor Kramer (Moments of Engagement, 1989--not reviewed) is a practicing psychiatrist who uses traditional techniques of therapy but also prescribes Prozac and other psychopharmaceuticals for his patients when they seem appropriate. Thanks to exposure on TV talk shows, Prozac is associated in many people's minds with suicide and violence, but only in the last chapter here--an appendix, really--does the author argue directly against these charges. What he explores instead are the far-reaching implications of the generally positive changes in temperament triggered by Prozac and other drugs prescribed to relieve anxiety and depression, and what these medications have taught us about how character and temperament are shaped. Prozac relieves mild depression, for instance, by elevating levels of serotonin in the brain. Knowledge of that fact opens the door to further investigation of chemical pathways in the brain, individual variations in levels of serotonin and other neurotransmitters, and perhaps even to early diagnosis and treatment of mood disorders. But, as Kramer points out, it also opens the possibility of altering brain chemistry to order, perhaps transforming a shy, sensitive individual into a sociable, assertive personality--the kind that present society most values. Acquisition of such a temperament, in fact, is the effect that Prozac has on many of Kramer's patients. But what has been lost when sensitivity is replaced by assertiveness? What is the ``real'' personality? Such thoughtful questioning is supported throughout by case histories and meaty reports on recent research. Some of the material suggests that if Freud was wrong about the content of childhood trauma (the Oedipal attachments), he was not wrong about its far-reaching effects. A wise and unflinching examination of the ramifications for society--and for the individual--when the capsule replaces the couch. -- Copyright ©1993, Kirkus Associates, LP. All rights reserved.

Customer Reviews

Has This Work Been With Us Ten Years Already?
I had a desire to go back and reread this work on the tenth anniversary of its publication. I was curious to see how Dr. Peter Kramer's magnificent essay of the mysteries of mood and matter had stood the test of time. I was also interested to see how far the psychiatric-pharmaceutical complex had come in the past decade in dealing with the scourge of depression and other mental disorders.

But before I get too far ahead of myself, exactly what was it about this book that made it such a provocative success in 1993? Two factors come to mind almost immediately. The first is the remarkable story-telling and philosophical style of the author. Yes, the crux of this work was the ethical dilemma of physicians who for the first time possessed the legal and medicinal power to alter personality cosmetically. But we forget over the years that this book was much more than a pharmaceutical morality play. It was a fascinating look at the pioneers of the biotechnology era, a glimpse into the hit and miss processes whereby paradigms and hypotheses were transformed into molecular formulas. The author made lucid for the general public just how mysterious the matrix between the material and the metaphysical truly is. That the new psychotropic drugs could morph a wallflower into a grand dame was becoming evident, so to speak, but the reasons for the change remained well educated guesses, and nothing more, in 1993. Such a tale was both tantalizing and troubling, and no one before Kramer had quite animated psychiatry while circumscribing it in such an elegant way.

The second attraction of this book was the drug itself, Fluoxetine, marketed under the brand name Prozac. Prozac was not the only member of new wave antidepressants, the Selective Serotonin Reuptake Inhibitors, or SSRI's, available in 1993. [Zoloft was on the market by then.] But Prozac intrigued the public for different reasons than it enthralled Dr. Kramer. Prozac had a public relations problem: allegedly it promoted suicide and other evils, charges easily discredited with time but not until the medication had run the Larry King/60 Minute gamut of journalistic fury. Kramer did for Prozac what the Crocodile Hunter would later do for venomous reptiles, remind us that though potent the SSRI's can be handled safely by trained professionals.

It has been ten years since this work was published, and seventeen years since the appearance of Prozac. Have we grown in wisdom regarding the relation of mood and chemicals in the human nervous system, and have we seen a stampede of new clients looking for psychological facelifts from new generation psychotropics? To respond to the first question, pharmaceutical inquiry over the past decade has continued to focus upon the neurotransmitter model of cellular communication in the brain--the cute Zoloft TV cartoon of little bullets or messengers passing back and forth between mother ships. There is now question as to whether Serotonin is the only bullet in the holster, with researchers looking at the roles of dopamine and norepinephrine in the alteration of mood. Moreover, the SSRI's have proven effective over time with more disorders besides depression--everything from obsessions to pain management. But no new major theory of mood disorder has displaced those discussed by Kramer. The kindling theory of illness described by Kramer [110ff.] and the genetic disposition toward illness in successive generations of families seem to have created more interest in pediatric psychiatry and the importance of early intervention. What has certainly changed in a decade is Prozac's reputation; it is now the safe old plow horse of the stable, the only SSRI considered truly tolerable for minors.

As to the second issue, personality enhancement, Kramer's worries may have been misplaced. Kramer was low keyed in his discussion of side effects, but the SSRI's have been bedeviled by them to the present day. Most notably the sexual side effects have put a damper upon elective use of the medication. Sexual impairment is a high price to pay for enhanced self confidence, though new formulations and time release capsules have ameliorated the side effects some. [The real stampede, ironically, has been toward Viagra.] But when push comes to shove, the past decade indicates that, bottom line, Americans continue to entertain a pharmaceutical Calvinism, a suspicion of medicine, and more recently, of the companies that make them. When I undertake a mental health assessment, the first question I get is inevitably: "You're not going to recommend drugs, are you?" One common example: parents resist stimulants for their ADHD children like the plague. Contrary to popular belief, America is not a country of eager pill poppers, and this has been true even before the recent surge in medicine costs. Pills are for "when you're sick."

If anything, there is a thinly veiled contempt for medical interventions that enhance the human experience beyond convention. Evidently there is a national consensus that every man deserves a good erection. But buried deep in the national subconscious is the spirit of the Hippocratic Oath. Or, conceivably, we have taught people to "just say no" a little too indiscriminately where medication is concerned. But by and large cosmetic physical interventions still carry a certain stigma. There is a slight revulsion to the idea that Barry Bonds' 73 home runs were steroid enhanced, or that Pamela Anderson's prime assets are [or were] primarily silicone. There have been pharmaceutical betrayals, too, in the last ten years, notably Redux and Fen Fen. In retrospect Kramer's fears about the ethics of altering personality have been trumped by the inbred suspicion of the "quick fix." Who among us does not hold an innate suspicion of ads for "miracle weight loss?" A nation reluctant to eat a steady diet of meat to lose weight is probably not ready for instant personality remakes.

A brilliant look at the implications of Prozac
This author is truly eloquent. Although he covers subjects ranging from the experiences of his own clients to more scientific discussions of how biology plays into the experience of depression, it never once lost my attention. After reading this book, I felt like I'd gotten a little "self-help" as well as a nice mini-course in the psychology and biology of the human being. Read this if you love someone who is depressed and is trying "new" antidepressants, not just because it will give you a good grasp of the workings of the drugs themselves, but also because it illuminates beautifully the day to day experiences of dealing with depression.

Best book I've read on topic of depression and treatment
Listening to Prozac bridges the gap between the medical profession and layperson, presenting cogent information about the effect of SRIs and the ever-broadening spectrum of mood and psychological disorders they can effectively treat. Kramer doesn't skirt the ethical issues, nor does he promote the use of of SRIs. He does recognize that thousands of doctors and millions of patients feel these drugs represent a true breakthrough in treating depression and mood disorders in many types of people. At the same time, he addresses the question of what we most of us call "character"--something that many believe to be fixed in an individual--and how it can undergo "change" during treatment with SRIs. This becomes an ethical and spiritual question (in addition to being a medical question). It is a question that was (is) fascinating to me.